DETAILED INFORMATION
The test is based on the detection of methylation of the Septin 9, SDC2, and BCAT1 genes in the patient’s circulating cell-free DNA. It is a highly sensitive Real-Time PCR method that can detect both colorectal cancer and precancerous changes.
Why is the test important?
Colorectal cancer is the third most common cancer worldwide and the second leading cause of cancer-related deaths. Early detection is crucial for improving patient survival. In the early stages, epigenetic changes are present, which the test can identify.
Who is the test suitable for:
-
Individuals over 40 years old.
-
Patients with blood in the stool, chronic inflammation of the colon, constipation, or hemorrhoids.
-
Patients with a family history of colorectal cancer, adenomas, or hereditary forms of cancer.
-
Patients with benign colorectal polyps or chronic ulcerative colitis.
-
Patients with type II diabetes, smokers, and individuals with an unhealthy lifestyle.
-
Patients after treatment for colorectal cancer (for recurrence monitoring).
-
Individuals who refuse preventive colonoscopy.
Test parameters:
-
Negative predictive value: 94.22 %
-
Positive predictive value: 84.75 %
What the test results mean:
-
Positive result: The patient is recommended to undergo a colonoscopy; contact: MUDr. Magdalena Stefanová, Na Františku Hospital (gastroenterology clinic).
-
Negative result: If symptoms persist, consult a specialist; it is recommended to repeat the test in 1 year.
Result delivery time: 15 working days